Banque Cantonale Vaudoise’s Ionis Pharmaceuticals IONS Stock Holding History

Banque Cantonale Vaudoise’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-400	Closed	-$19K	–	882
2024 Q2	$19K	Hold	400	–	–	﹤0.01%	889
2024 Q1	$17K	Hold	400	–	–	﹤0.01%	899
2023 Q4	$20K	Hold	400	–	–	﹤0.01%	899
2023 Q3	$18K	Hold	400	–	–	﹤0.01%	1076
2023 Q2	$16K	Hold	400	–	–	﹤0.01%	1080
2023 Q1	$14K	Sell	400 -879	-69%	-$33K	﹤0.01%	1090
2022 Q4	$48K	Buy	1,279 +879	+220%	+$37K	﹤0.01%	963
2022 Q3	$18K	Hold	400	–	–	﹤0.01%	1110
2022 Q2	$15K	Hold	400	–	–	﹤0.01%	1152
2022 Q1	$15K	Hold	400	–	–	﹤0.01%	1180
2021 Q4	$12K	Hold	400	–	–	﹤0.01%	1225
2021 Q3	$13K	Hold	400	–	–	﹤0.01%	1195
2021 Q2	$16K	Sell	400 -2,400	-86%	-$94K	﹤0.01%	1180
2021 Q1	$126K	Sell	2,800 -1,671	-37%	-$93.2K	0.01%	868
2020 Q4	$253K	Sell	4,471 -12	-0.3%	-$598	0.01%	670
2020 Q3	$212K	Sell	4,483 -2,326	-34%	-$129K	0.01%	666
2020 Q2	$401K	Buy	6,809 +2,459	+57%	+$137K	0.03%	452
2020 Q1	$205K	Sell	4,350 -59	-1%	-$3.29K	0.02%	617
2019 Q4	$266K	Buy	+4,409	New	+$263K	0.02%	648

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Banque Cantonale Vaudoise's IONS Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of Ionis Pharmaceuticals (IONS) in Q3 2024, closing a stake of 400 shares — an estimated $19K sold.

Banque Cantonale Vaudoise first reported a position in IONS in Q4 2019 and held it in 19 quarters. The position peaked at $401K in Q2 2020. 353 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

Banque Cantonale Vaudoise reported no remaining Ionis Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Banque Cantonale Vaudoise sold 400 Ionis Pharmaceuticals shares in Q3 2024, an estimated $19K.
Banque Cantonale Vaudoise first reported a position in Ionis Pharmaceuticals in Q4 2019 and held it in 19 quarters.
Banque Cantonale Vaudoise's Ionis Pharmaceuticals position peaked at $401K in Q2 2020.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.